REGN: Regeneron Pharmaceuticals, Inc. Stock

by  •  • Comments Off on REGN: Regeneron Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 85,075.90
Enterprise Value ($M) 68,772.50
Book Value ($M) 29,325.90
Book Value / Share 277.25
Price / Book 2.90
NCAV ($M) 19,296.50
NCAV / Share 182.43
Price / NCAV 4.41

Profitability (mra)
Return on Invested Capital (ROIC) 0.15
Return on Assets (ROA) 0.14
Return on Equity (ROE) 0.19

Liquidity (mrq)
Quick Ratio 5.33
Current Ratio 5.99

Balance Sheet (mrq) ($M)
Current Assets 27,412.50
Assets 37,441.90
Liabilities 8,116.00
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-13 13G/A Vanguard Group Inc 8.25 1.33
02-09 13G/A Fmr Llc 9.63 -7.03
02-09 13G/A Capital World Investors 4.80 -17.75
01-25 13G/A Jpmorgan Chase & Co 6.70 18.33
01-25 13G/A BlackRock Inc. 8.10 -5.86

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-02-05 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-14 132,200 862,097 15.33
2024-11-13 71,033 481,670 14.75
2024-11-12 87,929 536,764 16.38
2024-11-11 70,847 464,968 15.24

(click for more detail)

Similar Companies
QURE – uniQure N.V. RARE – Ultragenyx Pharmaceutical Inc.
RDUS – Radius Recycling, Inc. REPL – Replimune Group, Inc.
RGEN – Repligen Corporation


Financial data and stock pages provided by
Fintel.io